AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE
Publication
, Journal Article
Ranjan, T; Peters, KB; Vlahovic, G; Watts, J; Dutton, S; Boulton, S; Lipp, E; Herndon, J; Healy, P; Miller, E; Friedman, H; Karmali, R; Desjardins, A
Published in: Neuro-Oncology
November 1, 2014
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v19 / v19
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ranjan, T., Peters, K. B., Vlahovic, G., Watts, J., Dutton, S., Boulton, S., … Desjardins, A. (2014). AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology, 16(suppl 5), v19–v19. https://doi.org/10.1093/neuonc/nou237.47
Ranjan, T., K. B. Peters, G. Vlahovic, J. Watts, S. Dutton, S. Boulton, E. Lipp, et al. “AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v19–v19. https://doi.org/10.1093/neuonc/nou237.47.
Ranjan T, Peters KB, Vlahovic G, Watts J, Dutton S, Boulton S, et al. AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v19–v19.
Ranjan, T., et al. “AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v19–v19. Crossref, doi:10.1093/neuonc/nou237.47.
Ranjan T, Peters KB, Vlahovic G, Watts J, Dutton S, Boulton S, Lipp E, Herndon J, Healy P, Miller E, Friedman H, Karmali R, Desjardins A. AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v19–v19.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v19 / v19
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences